Midiagnostics
miDiagnostics is developing a next-generation diagnostic platform based on a silicon nanofluidic processor.
Total raised
€64M
€64,000,000
Funding rounds
3
Investors
5
distinct backers
Active since
2020-03
latest 2024-12
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood65
base rate 53% for Series D+
- ▲ In typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood19
base rate 12% (2+ rounds)
- ▲ 3 rounds raised
- ▲ €30M+ raised
- ▲ 11y since founding
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-12-04 | Series D+ | €30M | Alychlo,Pamica,Thermo Fisher Scientific Inc.,VMF Invest | View deal → |
| 2021-12-09 | Debt | €20M | European Investment Bank (EIB) | View deal → |
| 2020-03-26 | Other | €14M | — | View deal → |
Related news
- EIB invests €20M in Belgium-based miDiagnostics to help bring the pandemic under controlsiliconcanals.com · 2021-12
- tech.eu
- finsmes.com
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Imec€2.5BBelgium · Deeptech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Kpler€1.0BBelgium · Software